Forbes Magazine's 30 Under 30 for Science list of 2017 includes DNAsimple co-founder and CEO, Olivier Noel. You can see his profile and those of other winners on their website.
BuzzFeed covered several companies and issues around medical and genetic donations. Of course, only one had no up-front cost for donors -- can you guess which one?
The Boston Globe covers the rising biorights movement and details how DNAsimple is "one of the few companies to pay for routine biological samples for research." See the full article on their website.
This week, an article in Fast Company discusses how DNAsimple's innovative model compensates donors but, more importantly, gives them control over how donations are used.